Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to investigate the absorption of menaquinone-7 from a nutrient-enriched dairy product compared to a general dairy product enriched with menaquinone-7 and a menaquinone-7-containing supplement.
In an earlier study, beneficial effects of a nutrient-enriched dairy product on vitamin K-status were observed. The study product contained menaquinone-7 (MK-7) and omega-3 fatty acids for vascular health and extra minerals and antioxidants to support general health. It was the first time that such low dose of MK-7 (50 µg) could significantly improve vascular and general vitamin K-status already after short-term treatment. From the results of this study, it was assumed that the matrix of the dairy product and/or other components in the product, in which the vitamin was offered, contributed to optimal absorption and availability of vitamin K2. In this new study, the uptake and efficacy of MK-7 from the nutrient enriched product is investigated and compared to the uptake and efficacy from a MK-7-containing supplement and a basic dairy product enriched with MK-7.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| basic yogurt enriched with MK-7 | Active Comparator | one study group will receive daily two basic dairy products enriched with MK-7 (50 μg) |
|
| MK-7 containing capsule | Active Comparator | one study group will receive daily a softgel capsule consisting of 50 μg MK-7 |
|
| nutrient enriched yogurt with MK-7 | Active Comparator | one study group will receive daily two nutrient-enriched dairy products containing extra nutrients and omega-3 FA (fish-oil) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MK-7 containing capsule | Dietary Supplement |
| ||
| basic yogurt enriched with MK-7 |
| Measure | Description | Time Frame |
|---|---|---|
| The change in plasma MK-7 concentration after intervention between the three study groups | baseline and 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The change in circulating markers of vitamin K-status, undercarboxylated osteocalcin and desphospho-uncarboxylated matrix Gla-protein, after intervention between the three study groups. | baseline and 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The change in circulating vitamin D (25-hydroxy-vitamin D) after intervention between the study groups. | baseline and 6 weeks |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cees Vermeer, PhD | VitaK BV Maastricht University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VitaK BV / Maastricht University Medical Center | Maastricht | 6229 EV | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dietary Supplement |
|
| nutrient-enriched yogurt with MK-7 | Dietary Supplement |
|